908 Devices (NASDAQ:MASS – Get Free Report) and Inno (NASDAQ:INHD – Get Free Report) are both small-cap technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.
Analyst Recommendations
This is a summary of recent ratings and price targets for 908 Devices and Inno, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 908 Devices | 1 | 0 | 3 | 0 | 2.50 |
| Inno | 1 | 0 | 0 | 0 | 1.00 |
908 Devices currently has a consensus price target of $12.83, indicating a potential upside of 34.80%. Given 908 Devices’ stronger consensus rating and higher possible upside, research analysts clearly believe 908 Devices is more favorable than Inno.
Insider & Institutional Ownership
Risk & Volatility
908 Devices has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Inno has a beta of -24.12, indicating that its stock price is 2,512% less volatile than the S&P 500.
Earnings & Valuation
This table compares 908 Devices and Inno”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 908 Devices | $56.20 million | 7.00 | $19.49 million | ($0.95) | -10.02 |
| Inno | $2.85 million | 3.50 | -$7.08 million | ($5.90) | -0.67 |
908 Devices has higher revenue and earnings than Inno. 908 Devices is trading at a lower price-to-earnings ratio than Inno, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares 908 Devices and Inno’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 908 Devices | -56.96% | -12.54% | -8.87% |
| Inno | -72.63% | -9.47% | -9.36% |
Summary
908 Devices beats Inno on 12 of the 14 factors compared between the two stocks.
About 908 Devices
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
About Inno
Inno Holdings Inc. manufactures and sells cold-formed-steel members, castor cubes, mobile factories, and prefabricated homes in the United States. The company provides cold-formed steel framing and a mobile factory for off-site equipment rental, sales, service, and support. It serves in residential, commercial, industrial, and infrastructure projects. Inno Holdings Inc. was founded in 2019 and is headquartered in Brookshire, Texas.
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.
